These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 32740424)
1. Sex-related differences in chronic heart failure: a community-based study. Russo G; Rea F; Barbati G; Cherubini A; Stellato K; Scagnetto A; Iorio A; Corrao G; Di Lenarda A J Cardiovasc Med (Hagerstown); 2021 Jan; 22(1):36-44. PubMed ID: 32740424 [TBL] [Abstract][Full Text] [Related]
2. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction. Chen X; Savarese G; Dahlström U; Lund LH; Fu M Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205 [TBL] [Abstract][Full Text] [Related]
3. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications. Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874 [TBL] [Abstract][Full Text] [Related]
5. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study. Kontogeorgos S; Thunström E; Johansson MC; Fu M Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428 [TBL] [Abstract][Full Text] [Related]
6. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction. Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602 [TBL] [Abstract][Full Text] [Related]
7. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry. Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953 [TBL] [Abstract][Full Text] [Related]
8. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051 [TBL] [Abstract][Full Text] [Related]
9. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction. Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642 [TBL] [Abstract][Full Text] [Related]
10. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256 [TBL] [Abstract][Full Text] [Related]
11. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction. Sartipy U; Dahlström U; Fu M; Lund LH JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451 [TBL] [Abstract][Full Text] [Related]
14. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction. Son MK; Park JJ; Lim NK; Kim WH; Choi DJ Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140 [TBL] [Abstract][Full Text] [Related]
16. Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction. Tromp J; Shen L; Jhund PS; Anand IS; Carson PE; Desai AS; Granger CB; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Køber L; Swedberg K; Zile MR; Pitt B; Lam CSP; McMurray JJV J Am Coll Cardiol; 2019 Aug; 74(5):601-612. PubMed ID: 31370950 [TBL] [Abstract][Full Text] [Related]
17. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075 [TBL] [Abstract][Full Text] [Related]
18. Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction. Teng TK; Tay WT; Dahlstrom U; Benson L; Lam CSP; Lund LH Int J Cardiol; 2018 Mar; 254():203-209. PubMed ID: 29407092 [TBL] [Abstract][Full Text] [Related]
19. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV; Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058 [TBL] [Abstract][Full Text] [Related]
20. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data. Beldhuis IE; Streng KW; Ter Maaten JM; Voors AA; van der Meer P; Rossignol P; McMurray JJ; Damman K Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]